# US Congress Urges Novo Nordisk to Reduce Drug Prices ### Key Points: – Novo Nordisk is under pressure from the US Congress to lower the prices of its weight loss drugs. – The high cost of these medications has been a barrier for many individuals seeking help with managing their weight. – Congressional members have sent a letter to the pharmaceutical company, emphasizing the importance of making these drugs more affordable. – Novo Nordisk has yet to respond to these calls for pricing adjustments. In a move to make weight loss drugs more accessible, the US Congress has called upon Novo Nordisk to consider reducing the prices of their medications. Many people struggle with their weight and could benefit from these drugs, but the steep costs have been prohibitive for numerous individuals. The congressional letter highlights the urgency of addressing this issue and ensuring that these medications are affordable for those in need. It remains to be seen how Novo Nordisk will respond to these demands from lawmakers. **Hot take:** It is encouraging to see the US Congress advocating for greater affordability and access to weight loss medications. This initiative has the potential to positively impact the health and well-being of many individuals who are seeking effective solutions for managing their weight. For those looking for support on their weight loss journey, reaching out to Mindful Evolution could provide guidance and assistance in achieving their goals. Weight loss disclaimer: Individual results may vary. Mindful Evolution provides telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Please visit our website or contact us at 954-639-9960 for more information.